MARC Record from harvard_bibliographic_metadata

LEADER: 02725cam a22003858a 4500
001 010358743-8
005 20070614142952.0
008 061229s2007 paua b 001 0 eng
010 $a 2006103416
016 7 $a101296306$2DNLM
020 $a9780781787628 (alk. paper)
020 $a0781787629 (alk. paper)
035 0 $aocm77573161
040 $aDNLM/DLC$cDLC$dBAKER$dBTCTA$dNLM$dKUT$dHMS
042 $apcc
050 00 $aRC660$b.U43 2007
060 00 $a2007 E-723
060 10 $aWK 815$bU57d 2007
082 00 $a616.4/62$222
100 1 $aUnger, Jeff,$cM.D.
245 10 $aDiabetes management in primary care /$cJeff Unger.
260 $aPhiladelphia :$bWolters Kluwer Health/Lippincott Williams & Wilkins,$cc2007.
300 $axii, 706 p. :$bill. ;$c24 cm.
500 $aIncludes bibliographical references and index.
505 0 $aIntroduction to diabetes -- Diagnosing and managing the metabolic syndrome -- Polycystic ovary syndrome -- Managing type 2 diabetes in adults -- Physiologic insulin replacement therapy -- Insulin pump therapy -- Assessing glycemic control using home blood glucose monitoring, continuous glucose sensing, and glycated hemoglobin (A1C) testing -- Management of diabetes in pregnancy, childhood, and adolescence -- Lifestyle interventions for patients with diabetes -- In-patient management of patients with diabetes -- Screening, diagnosis, and management of diabetes-related complications.
505 8 $aAmylin, glucagon-like peptide-1 receptor agonists, and dipeptidylpeptidase IV (DPP-IV) inhibitors as novel treatments for diabetes -- Managing mental illness in patients with diabetes.
504 $aIncludes bibliographical references and index.
520 $aOffers primary care physicians evidence-based guidelines for evaluating and treating all patients with diabetes. It covers all aspects of outpatient and hospital-based diabetes care for all age groups, and includes behavioral interventions for enhancing patient adherence. Coverage includes fine-tuning glycemic management with computerized self-blood glucose monitoring software, evaluating and treating patients with metabolic syndrome and polycystic ovary syndrome, managing mental illness in patients with diabetes, and prevention of microvascular and macrovascular complications. The book discusses newer insulin therapy protocols, insulin delivery devices such as pumps, pens, and inhaled insulin, and novel pharmacotherapies including incretin mimetics and DPP-IV inhibitors.
650 0 $aDiabetes$xTreatment.
650 0 $aDiabetics$xRehabilitation.
650 0 $aPrimary care (Medicine)
650 12 $aDiabetes Mellitus$xtherapy.
650 22 $aPrimary Health Care.
988 $a20070513
906 $0OCLC